Results 131 to 140 of about 51,797 (271)
We compared the initial efficacy of denosumab (Dmab) and zoledronate (ZOL) in treatment‐naive patients with osteoporosis. This cohort study, based on TriNetX data, evaluated the risks of fractures and mortality using Kaplan–Meier survival analyses, with hazard ratios (HRs) and 95% confidence intervals (CIs).
Ko‐Hsiu Lu +2 more
wiley +1 more source
Xujuan Xu,1,* Biyu Shen,2,3,* Aixian Zhang,4 Jingwei Liu,3 Zhanyun Da,4 Hong Liu,4 Zhifeng Gu4 1Department of Nursing, Affiliated Hospital of Nantong University, 2School of Nursing, Nantong University, 3Department of Nursing, The Second Affiliated ...
Xu X +6 more
doaj
ABSTRACT Background Fibromyalgia is a syndrome characterised by widespread chronic pain, which is believed to be mediated by a state of central sensitisation (CS). Based on the hypothesis that CS itself could have genetic determinants, our aim was to further explore this pathway.
Nicolas Macian +8 more
wiley +1 more source
Ankylosing spondylitis (AS) is a chronic inflammatory disorder characterized by dysregulated T cells. We hypothesized that the aberrant expression of microRNAs (miRNAs) in AS T cells involved in the pathogenesis of AS.
Lai, N. -S.;Yu, H. -C.;Chen, H. -C.;Yu, C. -L.;Huang, H. -B.;Lu, M. -C. +1 more
core
ABSTRACT Aim Biologic agents play a pivotal role in controlling both articular and cutaneous manifestations of psoriatic arthritis (PsA). Although international guidelines emphasize the appropriate use of biologics, Korea lacks standardized treatment protocols tailored for PsA across specialties.
Bon San Koo +4 more
wiley +1 more source
Graeme Kohler BSc. (Health Education), MA (Health Promotion) School of Health and Human Performance, Dalhousie University Objective: To understand the experiences of young men living with Ankylosing Spondylitis (AS).
Kohler, Graeme Patrick
core
New approaches in ankylosing spondylitis
Free to read on journal website (may need to create free account first)\ud \ud There have been marked improvements in treatment options but none have yet been shown to induce remission\ud \ud The past decade has seen major advances in the diagnosis and ...
Bradbury, Linda A. +3 more
core +1 more source
ABSTRACT Background We aimed to investigate and characterise DILI due to approved therapies for inflammatory bowel disease (IBD). Methods Using the Drug‐Induced Liver Injury Network (DILIN) prospective study, we evaluated definite, highly likely, or probable DILI attributed to IBD therapies, including use for non‐IBD indications (but excluding ...
Harish Gopalakrishna +9 more
wiley +1 more source
Background and objectives: Ankylosing spondylitis is a persistent inflammatory rheumatic condition that predominantly affects the axial skeleton. The current research aims to assess the correlation between disease activity and the C-reactive protein to ...
Avin Mariwan Mohammed Saleh +1 more
doaj +1 more source

